alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 270 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 270

   To continue the use of a 3-month quarter EHR reporting period for 
health care providers to demonstrate meaningful use for 2015 under the 
  Medicare and Medicaid EHR incentive payment programs, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 12, 2015

 Mrs. Ellmers (for herself, Mr. Kind, Mr. David Scott of Georgia, Mrs. 
 Blackburn, and Mr. Thompson of Pennsylvania) introduced the following 
 bill; which was referred to the Committee on Energy and Commerce, and 
  in addition to the Committee on Ways and Means, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL

 
   To continue the use of a 3-month quarter EHR reporting period for 
health care providers to demonstrate meaningful use for 2015 under the 
  Medicare and Medicaid EHR incentive payment programs, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Flexibility in Health IT Reporting 
(Flex-IT) Act of 2015''.

SEC. 2. CONTINUING USE OF 3-MONTH QUARTER EHR REPORTING PERIODS FOR 
              PROFESSIONALS AND HOSPITALS TO DEMONSTRATE MEANINGFUL USE 
              FOR 2015 UNDER THE MEDICARE AND MEDICAID EHR INCENTIVE 
              PAYMENT PROGRAMS.

    In specifying the EHR reporting period under part 495 of title 42, 
Code of Federal Regulations, for purposes of titles XVIII and XIX of 
the Social Security Act, the Secretary of Health and Human Services 
shall continue through 2015 (in the case of eligible professionals) and 
fiscal year 2015 (in the case of eligible hospitals and critical access 
hospitals) to permit the use of a 3-month quarter EHR reporting period 
to demonstrate meaningful use for purposes of such part, without regard 
to the payment year or the stage of meaningful use criteria involved.
                                 <all>
```
Electronically Filed Intermediate Court of Appeals CAAP-15-0000662 13-DEC-2016 08:13 AM
```

CONFIRMING STATEMENT

    This statement confirms that the undersigned, Jeffrey B. Lorentson, has authorized and designated, Jennifer Mainord, Amanda C. Williams or Rhonda Bost, to execute and file on the undersignedTMs behalf, all Form 3, 4, and 5 (including amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersignedTMs ownership of or transactions in securities of First Merchants Corporation.  The authority of Jennifer Mainord, Amanda C. Williams or Rhonda Bost under this statement shall continue until the undersigned is no longer required to file Form 3, 4, and 5 with regard to the undersigned ownership or transactions in securities of First Merchants Corporation, unless earlier revoked in writing.  The undersigned acknowledges Jennifer Mainord, Amanda C. Williams or Rhonda Bost are not assuming any of the undersignedTMs responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

                        __/s/ Jeffrey B. Lorentson______
                        Jeffrey B. Lorentson

Date: February 13, 2014
```
```

[Federal Register Volume 89, Number 179 (Monday, September 16, 2024)]
[Notices]
[Page 75548]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20916]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Dental & Craniofacial Research; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Grants Review Committee.
    Date: October 24-25, 2024.
    Time: 9:00 a.m. to 5:00 p.m..
    Agenda: To review and evaluate grant applications.
    Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 
20852 (Hybrid Meeting).
    Contact Person: Aiwu Cheng, Ph.D., Scientific Review Officer, 
National Institute of Dental and Craniofacial Research, National 
Institutes of Health, 6701 Democracy Blvd., Bethesda, MD 20982, 
(301) 594-4859, email: [email protected].

(Catalogue of Federal Domestic Assistance Program No. 93.121, Oral 
Diseases and Disorders Research, National Institutes of Health, HHS)

    Dated: September 10, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-20916 Filed 9-13-24; 8:45 am]
BILLING CODE 4140-01-P
```
EXHIBIT 23--CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
--------------------------------------------------------------------------------
We hereby consent to the incorporation by reference to Registration Statements
on Form S-8, File Number 33-28900 and 33-28901, or our report dated January 15,
1999, on the consolidated financial statements of First Merchants Corporation,
which report is incorporated by reference in the Annual Report on Form 10-K of
First Merchants Corporation.

/s/ Olive LLP

Indianapolis, Indiana
March 22, 1999
EXHIBIT 32.1

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. § 1350, as created by
Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of SCPIE Holdings Inc. (the Company) hereby certifies, to such officers knowledge, that:

(i) the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2008 (the
Report) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.



|                   |  |  |  |                                      
|------------------ |  |  |  | -------------------------------------
|                   |  | 
|Dated: May 8, 2008 |  |  |  | /s/ Donald J. Zuk                    
|                   |  |  |  | Donald J. Zuk Chief Executive Officer

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350,
and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any
general incorporation language in such filing.
II 

115TH CONGRESS 

2D SESSION S. 2711 

To amend section 303 of the Controlled Substances Act to facilitate waivers 

of the separate registration requirement for physicians dispensing narcotic drugs to individuals for maintenance treatment or detoxification 

treatment. 

IN THE SENATE OF THE UNITED STATES 

APRIL 19, 2018 

Ms. HASSAN (for herself and Mr. PORTMAN) introduced the following bill; 

which was read twice and referred to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To amend section 303 of the Controlled Substances Act 

to facilitate waivers of the separate registration requirement for physicians dispensing narcotic drugs to individuals for maintenance treatment or detoxification treatment. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Enhancing Access to 

5 Addiction Treatment Act of 2018’’. 


lotter on DSKBCFDHB2PROD with BILLS
2 

•S 2711 IS

1 SEC. 2. WAIVERS FOR MAINTENANCE OR DETOXIFICATION 

2 TREATMENT. 

3 (a) WAIVER.—Section 303(g)(2)(G)(ii) of the Con4 trolled Substances Act (21 U.S.C. 823(g)(2)(G)(ii)) is 

5 amended by adding at the end the following: 

6 ‘‘(VIII) The physician graduated from an 

7 accredited school of allopathic medicine or os8 teopathic medicine in the United States during 

9 the 5-year period ending on the date on which 

10 the physician submits to the Secretary a written 

11 notification under subparagraph (B) and suc12 cessfully completed a comprehensive allopathic 

13 or osteopathic medicine curriculum or accred14 ited medical residency that— 

15 ‘‘(aa) included not less than 24 hours 

16 of training on treating and managing opi17 ate-dependent patients; and 

18 ‘‘(bb) included, at a minimum— 

19 ‘‘(AA) the training described in 

20 items (aa) through (gg) of subclause 

21 (IV); and 

22 ‘‘(BB) training with respect to 

23 any other best practice the Secretary 

24 determines should be included in the 

25 curriculum, which may include train26 ing on pain management, including 


lotter on DSKBCFDHB2PROD with BILLS
3 

•S 2711 IS

1 assessment and appropriate use of 

2 opioid and non-opioid alternatives.’’. 

3 (b) GRANTS.— 

4 (1) IN GENERAL.—The Secretary of Health and 

5 Human Services shall establish a grant program 

6 under which the Secretary may make grants to ac7 credited schools of allopathic medicine or osteopathic 

8 medicine and teaching hospitals located in the 

9 United States to support the development of cur10 ricula that meet the requirements under subclause 

11 (VIII) of section 303(g)(2)(G)(ii) of the Controlled 

12 Substances Act, as added by subsection (a). 

13 (2) AUTHORIZATION OF APPROPRIATIONS.— 

14 There are authorized to be appropriated for grants 

15 under paragraph (1), $4,000,000 for each of fiscal 

16 years 2019 through 2023. 

17 (c) TECHNICAL AMENDMENT.—Section 102(24) of 

18 the Controlled Substances Act (21 U.S.C. 802(24)) is 

19 amended by striking ‘‘Health, Education, and Welfare’’ 

20 and inserting ‘‘Health and Human Services’’. 

Æ 


lotter on DSKBCFDHB2PROD with BILLS
# C_2022363EN.01000301.xml

| 22.9.2022 | EN | Official Journal of the European Union | C 363/3 |
| --- | --- | --- | --- |

22.9.2022

EN

Official Journal of the European Union

C 363/3

---

Non-opposition to a notified concentration

(Case M.10846 – CVC FUNDS / VISMA CUSTOM SOLUTIONS)

(Text with EEA relevance)

(2022/C 363/03)

On 16 September 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10846. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10846. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
# C_2022464EN.01000401.xml

| 6.12.2022 | EN | Official Journal of the European Union | C 464/4 |
| --- | --- | --- | --- |

6.12.2022

EN

Official Journal of the European Union

C 464/4

---

Non-opposition to a notified concentration

(Case M.10790 – SALIC / OLAM / OLAM AGRI)

(Text with EEA relevance)

(2022/C 464/04)

On 18 November 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10790. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10790. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
##### 



Exhibit 32.1 CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Otter Tail Corporation (the Company) on Form 10-K for the
period ended December 31, 2004 as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, John D. Erickson, President and Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:  1.
    The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and2.
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company. /s/ John D. EricksonJohn D. EricksonPresident and Chief Executive OfficerMarch 14, 2005
# TIME AND DATE:

Monday, February 14, 2000, 11:30 a.m.

# LOCATION:

Room 410, East West Towers, 4330 East West Highway, Bethesda, Maryland.

# STATUS:

*Closed to the Public.*

*Matter to be Considered:*

*Compliance Operational Matter (OS# 5756)*

The Commission and staff will discuss a compliance operational matter.

For a recorded message containing the latest agenda information, call (301) 504-0709.

# CONTACT PERSON FOR ADDITIONAL INFORMATION:

Sadye E. Dunn, Office of the Secretary, 4330 East West Highway, Bethesda, MD 20207 (301) 504-0800.

Dated: February 7, 2000.

Sadye E. Dunn,

Secretary.

[FR Doc. 00-3151  Filed 2-7-00; 2:58 pm]

BILLING CODE 6355-01-M
MEMORANDUM OPINION

No. 04-11-00362-CR

Rupert TREVINO,

Appellant

v.

The STATE of Texas,

Appellee

From the 227th Judicial District Court, Bexar County, Texas

Trial Court No. 2010CR8538

Honorable Philip A. Kazen, Jr., Judge Presiding

PER CURIAM

Sitting: Sandee Bryan Marion, Justice

Phylis J. Speedlin, Justice

Rebecca Simmons, Justice

Delivered and Filed: July 20, 2011

DISMISSED

The trial court signed a certification of defendant’s right to appeal stating that this “is a 

plea-bargain case, and the defendant has NO right of appeal” and “defendant has waived the 

right of appeal.” See TEX. R. APP. P. 25.2(a)(2). Rule 25.2(d) provides, “The appeal must be 

dismissed if a certification that shows the defendant has the right of appeal has not been made 

part of the record under these rules.” TEX. R. APP. P. 25.2(d). Accordingly, on June 10, 2011, 

this court issued an order stating this appeal would be dismissed pursuant to Rule 25.2(d) unless 
04-11-00362-CR

- 2 -

an amended trial court certification that shows defendant has the right of appeal was made part of 

the appellate record. See Daniels v. State, 110 S.W.3d 174 (Tex. App.—San Antonio 2003, 

order); TEX. R. APP. P. 25.2(d); 37.1. No amended trial court certification has been filed; 

therefore, this appeal is dismissed.

PER CURIAM

Do not publish
**Exhibit 31.3**

 

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

 

I, Robert B. Crowl, certify that:

 

1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of PHH Corporation; and

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

 
|     | By:      | /s/Robert B. Crowl                        |     |
|----------|----------|-------------------------------------------|----------|
|     |     | Robert B. Crowl                           |     |
| * * | * * | *President and Chief Executive   Officer* | * * |

 

Date: April 23, 2018

 

----
<PAGE>   1

                                                                   Exhibit 10.56

                            FIFTH AMENDMENT TO LEASE


         This Fifth Amendment to Lease is entered into this 22nd day of April,
1998, between ROGER KUSKE ("Lessor") and GRAFALLOY CORPORATION ("Lessee") with
reference to the following facts:

                                    RECITALS

         A. Lessor (by virtue of an Assignment and Assumption Agreement) and
Lessee (also by virtue of an Agreement of Assignment and Assumption) are parties
to a Standard Industrial/Commercial Single-Tenant Lease-Net dated July 21, 1993
and to Amendments dated August 31, 194, March 5, 1996, February 24, 1997, and
August 29, 1997, respectively (the "Lease"), pursuant to which lessee has leased
that certain improved real property commonly known as 1020 North Marshall
Avenue, El Cajon, California ("the Property").

         B. The Lessor and Lessee desire to extend the term of the Lease,
provide the Lessee with an option to expand the space included in the Property
and to modify the Base Rent.

         NOW THEREFORE, in consideration of the mutual promises and covenants
between the parties, and for good and valuable consideration, the receipt and
adequacy of which is hereby acknowledged, Lessor and Lessee agree as follows:

         1. Term. The Term of the Lease shall be extended up to and including
September 30, 1999 ("Expiration Date").

         2. Base Rent. Commencing on October 1, 1998, the Base Rent payable
under the Lease, as amended, shall be adjusted to sixteen thousand dollars
($16,000.00) per month, net, net, net.

         3. Option to Extend. Prior to December 31, 1998, Lessee shall have the
option to extend the term of this Lease until September 30, 2003, provided that:

          a. Lessor must receive written notice from Lessee of Lessee's intent
to exercise this option by 5:00 p.m. on December 31, 1998;

          b. The square footage of the space included in the Property shall be
increased to approximately 33,200 square feet not less than sixty (60) days
after Lessor's receipt of Lessee's notice or later than March 1, 1999;

          c. The Base Rent for the first year following the delivery of the
additional space to lessee shall be increased to $18,260.00 per month, net, net,
net; and

          d. The Base Rent shall be increased annually on the anniversary of the
delivery of the additional space at the rate of four percent (4%) per annum.



                                       1
<PAGE>   2

         4. All other terms of the Lease shall remain in full force and effect.

LESSOR:

/s/   Roger Kuske
    --------------------------------
      Roger Kuske

LESSEE:

GRAFALLOY CORPORATION

/s/   William M. Gerhart
------------------------------------
By:  William M. Gerhart
Its:  President


                                       2
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL OF FLORIDA SECOND DISTRICT DEANDRICK KEYON BACON, ) ) Appellant, ) ) v. ) Case No. 2D17-504 ) STATE OF FLORIDA, ) ) Appellee. ) ) Opinion filed November 7, 2018. Appeal from the Circuit Court for Manatee County; Hunter Carroll, Judge. J. Andrew Crawford of J. Andrew Crawford, P.A., Saint Petersburg, for Appellant. Pamela Jo Bondi, Attorney General, Tallahassee, and Michael Schaub, Assistant Attorney General, Tampa, for Appellee.
PER CURIAM.

Affirmed. KHOUZAM, SLEET, and LUCAS, JJ., Concur.
**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

 

**FORM 8-K**

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

**DATE OF REPORT (Date of earliest event reported): October 30, 2009**

 

**FIRST MERCHANTS CORPORATION**

(Exact name of registrant as specified in its charter)

 

|   | INDIANA | 0-17071 | 35-1544218 |
|--------|---------|---------|------------|

 (State or other jurisdiction                 (Commission File Number)(IRS Employer Identification No.)

|   | of incorporation) |
|--------|-------------------|

 

**200 East Jackson Street**

**P.O. Box 792**

**Muncie, IN 47305-2814**

(Address of principal executive offices, including zip code)

 

**(765) 747-1500**

(Registrant's telephone number, including area code)

 

**Not Applicable**

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

**o****Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)**

**o****Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)**

**o****Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))**

**o****Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))**

 

 

 

----
**Final Listing of Questionnaire Files for Steam Electric Rulemaking Record**

**Plant ID 02068**  **Removed from Public**  **(Non-CBI) Docket**  **1 Copyright** 

**Flag 2**  **File Name Description**  x 

### 02068\02068_Checklist_102610_version34.xls EPA Technical Review Checklist Workbook



### 02068\02068_Completeness_Checklist.xls EPA Completeness Review Checklist 

### 02068\02068_HardcopyLog.doc Plant submitted survey file x 

### 02068\02068_PartA.xls Plant submitted survey file x 

### 02068\02068_PartE.xls Plant submitted survey file x 

### 02068\02068_PartH.xls Plant submitted survey file



### 02068\Certification Statement_02068.pdf Plant certification statement 

### 02068\Supporting Documentation\02068_MAP-1 CCPP.pdf Plant submitted supplemental files to the survey 02068\Supporting Documentation\02068_MAP-2 CCPP.pdf Plant submitted supplemental files to the survey x 02068\Supporting Documentation\02068_WB-1 CCPP.pdf Plant submitted supplemental files to the survey

02068\Supporting Documentation\Tranismittal Letter CCPP (16-Sep-10).pdf Plant submitted supplemental files to the survey

2Copyright documents are available from the docket. 1Final reviewed survey responses are located in the Steam Electric Technical Questionnaire Database
.